Local Control After Stereotactic Body Radiation for Liver Tumors

被引:67
|
作者
Ohri, Pelvis Nitin [1 ]
Tome, Wolfgang A. [1 ]
Romero, Alejandra Mendez [2 ]
Miften, Moyed [3 ]
Ten Haken, Randall K. [4 ]
Dawson, Laura A. [5 ]
Grimm, Jimm [6 ]
Yorke, Ellen [7 ]
Jackson, Andrew [7 ]
机构
[1] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Radiat Oncol, 1300 Morris Pk Ave,Block Bldg Room 106, Bronx, NY 10467 USA
[2] Erasmus MC Canc Inst, Dept Radiat Oncol, Rotterdam, Netherlands
[3] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO USA
[4] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[5] Univ Toronto, Princess Margaret Canc Ctr, Dept Radiat Oncol, Radiat Med Program, Toronto, ON, Canada
[6] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
[7] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
关键词
SMALL HEPATOCELLULAR-CARCINOMA; CELL LUNG-CANCER; PHASE-I/II TRIAL; RADIOTHERAPY; THERAPY; METASTASES; MANAGEMENT; SBRT;
D O I
10.1016/j.ijrobp.2017.12.288
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To quantitatively evaluate published experiences with hepatic stereotactic body radiation therapy (SBRT), to determine local control rates after treatment of primary and metastatic liver tumors and to examine whether outcomes are affected by SBRT dosing regimen. Methods and Materials: We identified published articles that reported local control rates after SBRT for primary or metastatic liver tumors. Biologically effective doses (BEDs) were calculated for each dosing regimen using the linear-quadratic equation. We excluded series in which a wide range of BEDs was used. Individual lesion data for local control were extracted from actuarial survival curves, and data were aggregated to form a single dataset. Actuarial local control curves were generated using the Kaplan-Meier method after grouping lesions by disease type and BED (<100 Gy(10) vs >100 Gy(10)). Comparisons were made using log-rank testing. Results: Thirteen articles met all inclusion criteria and formed the dataset for this analysis. The 1-, 2-, and 3-year actuarial local control rates after SBRT for primary liver tumors (n = 431) were 93%, 89%, and 86%, respectively. Lower 1-(90%), 2-(79%), and 3-year (76%) actuarial local control rates were observed for liver metastases (n = 290, log-rank P = .011). Among patients treated with SBRT for primary liver tumors, there was no evidence that local control is influenced by BED within the range of schedules used. For liver metastases, on the other hand, outcomes were significantly better for lesions treated with BEDs exceeding 100 Gy(10) (3-year local control 93%) than for those treated with BEDs of <= 100 Gy(10) (3-year local control 65%, P < .001). Conclusions: Stereotactic body radiation therapy for primary liver tumors provides high rates of durable local control, with no clear evidence for a dose -response relationship among commonly utilized schedules. Excellent local control rates are also seen after SBRT for liver metastases when BEDs of >100 Gy(10) are utilized. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:188 / 195
页数:8
相关论文
共 50 条
  • [1] Local Control Following Stereotactic Body Radiation Therapy for Liver Tumors
    Klement, Rainer J.
    Andratschke, Nicolaus
    Guckenberger, Matthias
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (01): : 249 - 250
  • [2] Stereotactic Body Radiation Therapy After Other Minimally-Invasive Local Therapies for Liver Tumors
    Barney, B. M.
    Callstrom, M. R.
    Merrell, K. W.
    Hardie, J. G.
    Olivier, K. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S316 - S316
  • [3] Predicting Liver Volume Changes After Stereotactic Body Radiation Therapy for Liver Tumors
    Shaffer, J.
    Koong, A. C.
    Chang, D. T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S323 - S323
  • [4] Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors
    Parker, Sean M.
    Siochi, R. Alfredo
    Wen, Sijin
    Mattes, Malcolm D.
    [J]. PRACTICAL RADIATION ONCOLOGY, 2019, 9 (01) : E90 - E97
  • [5] OBSERVATION OF A DOSE-CONTROL RELATIONSHIP FOR LUNG AND LIVER TUMORS AFTER STEREOTACTIC BODY RADIATION THERAPY
    McCammon, Robert
    Schefter, Tracey E.
    Gaspar, Laurie E.
    Zaemisch, Rebekah
    Gravdahl, Daniel
    Kavanagh, Brian
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01): : 112 - 118
  • [6] Imaging changes after stereotactic body radiation therapy for lung and liver tumors
    Lo, Simon S.
    Teh, Bin S.
    Wang, Jian Z.
    Huang, Zhibin
    Zook, Jennifer
    Price, Tracy
    Mayr, Nina A.
    Grecula, John C.
    Timmerman, Robert D.
    Cardenes, Higinia R.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 613 - 620
  • [7] Posttreatment PET-CT is Predictive of Local Control After Liver Stereotactic Body Radiation Therapy
    White, E. C.
    Shaffer, J.
    Kumar, K. A.
    Binkley, M. S.
    Koong, A. C.
    Chang, D. T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E181 - E181
  • [8] Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors
    Romero, Alejandra Mendez
    Wunderink, Wouter
    van Os, Rob M.
    Nowak, Peter J. C. M.
    Helimen, Ben J. M.
    Nuyttens, Joost J.
    Brandwijk, Rene P.
    Verhoef, Cornelis
    Ijzermans, Jan N. M.
    Levendag, Peter C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (05): : 1447 - 1452
  • [9] An Institutional Review of Stereotactic Body Radiation Therapy for Liver Tumors
    Merrell, K. W.
    Barney, B. M.
    Park, S. S.
    Laack, N. N.
    Haddock, M. G.
    Miller, R. C.
    Olivier, K. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S322 - S323
  • [10] Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors
    Liu, Erqi
    Stenmark, Matthew H.
    Schipper, Matthew J.
    Balter, James M.
    Kessler, Marc L.
    Caoili, Elaine M.
    Lee, Oliver E.
    Ben-Josef, Edgar
    Lawrence, Theodore S.
    Feng, Mary
    [J]. TRANSLATIONAL ONCOLOGY, 2013, 6 (04) : 442 - 446